Canine Angiostrongyl Infection in Dogs (Canine Angiostrongylosis)
- Synonyms: Angiostrongylus infection
- Occurrence: common
- Location of disease: Chest
When to visit the vet?
Urgent see a veterinarian within 24 hours
If the condition worsens / symptoms persist, consult a veterinarian.
Das Wichtigste auf einen Blick
Canine angiostrongylosis is a parasitic infection caused by the nematode Angiostrongylus vasorum, which affects dogs and other canids. The parasite has a complex life cycle that includes snails and slugs as intermediate hosts. Dogs become infected by consuming these intermediate hosts or contaminated materials. After infection, the larvae migrate through the dog’s body to the pulmonary arteries, where they mature into adult worms and lay eggs. These eggs develop into larvae that are excreted through the respiratory tract. Symptoms of infection may include sneezing, cough, nasal discharge, and in severe cases, neurological problems. Diagnosis is made through stool examinations and serological tests. Treatment includes antiparasitic medications such as moxidectin and milbemycin, as well as supportive measures for severe infections. The prognosis depends on the severity of the infection and the speed of treatment. Preventive measures include avoiding contact with snails and regular deworming. Research focuses on improving diagnostic methods, developing treatment options, and preventive strategies such as vaccines. International research, supported by modern technologies, aims to improve disease control. Early diagnosis and treatment are crucial to increase the chances of complete recovery.
Ursachen
Angiostrongylus vasorum is a nematode that infects dogs and other canids as its definitive host. The life cycle of this parasite is complex and involves intermediate hosts such as snails and slugs, which ingest the worm’s larvae. Dogs become infected by consuming these intermediate hosts or contaminated materials.
After ingestion, the larvae enter the dog’s body via the digestive tract. They migrate through the intestinal wall into the blood vessels and from there to the pulmonary arteries and the right heart. There, they mature into adult worms and begin to lay eggs. These eggs develop into larvae that enter the airways and are eventually excreted via the feces to complete the life cycle.
The distribution of Angiostrongylus vasorum is worldwide, but prevalence varies by geographic region. Humid climates where snails thrive favor the spread of the parasite. The increasing mobility of dogs also contributes to the spread of the infection.
Symptoms
The symptoms of angiostrongylosis can vary greatly and depend on the severity of the infection and the affected dog’s response. Common symptoms include cough, shortness of breath, and general respiratory distress, as the worms affect the lungs and airways.
Additionally, infected dogs may show lethargy, weight loss, loss of appetite, and general weakness. In severe cases, heart problems, coagulation disorders, and neurological symptoms such as seizures may occur.
Another sign of infection may be an increased tendency to bleed, which can manifest as nosebleeds, bloody cough, or blood in the urine. These symptoms result from damage to blood vessels caused by the parasites.
Key symptoms: Respiratory distress + reduced exercise tolerance, combined with unexplained bleeding tendencies or alternating “bronchitis/pneumonia” episodes. Suspicion especially high in regions with many snails and frogs.
Diagnose
The diagnosis of canine angiostrongylosis is based on a combination of clinical symptoms, medical history, and specific diagnostic tests. An important test is the examination of a stool sample to detect the parasite’s larvae. This test is called the Baermann technique and is a key diagnostic tool.
Additionally, serological tests can be performed to detect antibodies against Angiostrongylus vasorum in the blood. These tests help confirm an infection, especially when direct detection of larvae is difficult.
In some cases, a chest X-ray or cardiac ultrasound may be necessary to assess the condition of the lungs and heart and to rule out other possible causes of the symptoms.
Therapie
Treatment of canine angiostrongylosis requires the administration of antiparasitic medications that are specifically effective against nematodes. Moxidectin and milbemycin are two commonly used medications that can be administered orally or by injection.
In severe cases, supportive treatment may be necessary to alleviate the symptoms. This may include the administration of oxygen, fluid therapy, and medications to stabilize heart function. Anti-inflammatory drugs can also be used to reduce the inflammatory responses in the lungs.
It is important to carry out the treatment under veterinary supervision and to monitor the dog carefully during and after the treatment to ensure that it recovers fully.
Prognose und Nachsorge
The prognosis for dogs with angiostrongylosis depends on several factors, including the dog’s health status, the severity of the infection, and the speed with which treatment is initiated. Generally, dogs that are diagnosed and treated early have a good prognosis.
However, if left untreated, the infection can cause serious complications and, in the worst case, lead to death. Timely diagnosis and treatment are crucial to increase the chances of complete recovery.
After treatment, it is important to monitor the dog regularly for relapses or reinfection, as there is a risk of reinfection, especially in areas with high parasite prevalence.
Prävention
Prevention of canine angiostrongylosis focuses on avoiding contact with the parasite’s intermediate hosts. Dogs should be prevented from eating snails or slugs, and care should be taken to keep them in clean, well-maintained environments.
Regular deworming with appropriate medications can help minimize the risk of infection. It is advisable to consult a veterinarian to create a suitable deworming plan tailored to the dog’s specific needs and exposure risk.
In areas with known parasite prevalence, the use of antiparasitics that specifically target Angiostrongylus vasorum may also be considered for prophylaxis. However, these should only be used after consultation with a veterinarian to avoid overmedication.
Ausblick auf aktuelle Forschung
Canine angiostrongylosis, an infection with the lungworm Angiostrongylus vasorum, is an increasingly significant problem in veterinary medicine, particularly in Europe. In recent years, research has begun to focus more intensively on this disease to improve diagnosis, treatment, and prevention. One of the most important research areas is the study of the parasite’s distribution patterns. In Europe, it has been shown that the distribution area of Angiostrongylus vasorum is expanding, partly due to climate change and the behavior of intermediate hosts such as snails and frogs. Research is investigating how these environmental factors influence prevalence and spread.
Another focus of research is on the development of new diagnostic methods. Currently, serological tests that detect antibodies or antigens of the parasite in the blood are considered promising tools. These tests can enable early diagnosis before clinical symptoms appear. Studies are examining the sensitivity and specificity of these tests to improve their reliability. In parallel, research is also being conducted on molecular diagnostic methods based on PCR technology to directly detect the parasite’s genetic material.
Treatment of canine angiostrongylosis typically involves antiparasitics that kill the worm. Research focuses on the efficacy and safety of various active ingredients, particularly because some dogs may experience side effects after treatment. Alternative treatment strategies are also being investigated to avoid resistance and minimize side effects. This includes research into combination therapies or new drug classes.
Prevention of infection is also an important research topic. Scientists are working on developing vaccines that could protect dogs from infection. Although there is currently no approved vaccine against Angiostrongylus vasorum, initial studies show promising results in generating an immune response in dogs. In parallel, research is also being conducted on biological control of snail populations to reduce parasite transmission.
Another aspect of research is the investigation of pathogenesis, the developmental mechanisms of the disease in the dog’s body. Researchers are trying to understand how the parasite influences the dog’s immune system and what factors lead to different disease courses. These insights could help improve the prognosis for affected dogs and develop more targeted therapies.
Additionally, the role of co-infections is being investigated, as dogs with angiostrongylosis often also have other parasitic or bacterial infections. The interaction between different pathogens and their effects on the dog’s immune system are the subject of current studies. The goal is to develop more comprehensive treatment approaches that address all aspects of the infection.
Research work is supported by the use of modern technologies such as genome sequencing and bioinformatics, which enable a better understanding of the parasite’s genetic structure. This allows new target structures for therapeutic approaches to be identified. International collaboration between research institutions also contributes to the rapid advancement of knowledge in this field.
Overall, current research shows that canine angiostrongylosis is a complex and multifaceted problem that requires a multidisciplinary approach. However, advances in diagnosis, treatment, and prevention give reason to hope that control of this disease can be made more effective in the near future.